<DOC>
	<DOCNO>NCT00385645</DOCNO>
	<brief_summary>The study compare adherence 240 HIV-negative subject randomly assign 2 different antiretroviral therapy 28 day accidental exposure HIV .</brief_summary>
	<brief_title>Atazanavir Lopinavir HIV Post-exposure Prophylaxis</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Lamivudine , zidovudine drug combination</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Age &gt; 18 HIV exposure require prophylaxis current guideline Pregnancy Suspected drug resistance source case Contraindications study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>HIV seronegativity</keyword>
</DOC>